Tag Archive for USANA

USANA Q2 Revenue 11% Down To $213 Million

USANA Health Sciences, Inc.announced financial results for its fiscal second quarter ended June 29, 2024.
Key Financial & Operating Results

Second quarter net sales were $213 million versus $238 million during Q2 2023.
Second quarter diluted EPS was $0.54 as compared with $0.89 during Q2 2023.
Company updates fiscal year 2024 net sales and diluted EPS outlook to $850 million to $880 million and $2.40 to $2.55 (previously $850 million to $920 million and $2.40 to $3.00).

“Second quarter operating results were below our expectations,”

said Jim Brown, President and Chief Executive Officer.

“Ongoing macroeconomic pressures in several of our key markets continue to impact consumer spending. This in turn creates challenges in our ability to attract and engage new customers and generate sales momentum.
To counter these challenges, we have made several strategic changes in our business over the past few quarters, including (i) restructuring our commercial team, (ii) heightening our focus on product innovation, (iii) increasing our efforts to engage our sales leaders with an Associate-first approach, (iv) expanding into India, and (v) evaluating more business development activities.
“Next month, we will be hosting our Americas & Europe Convention in Las Vegas, Nevada along with other Associate engagement-focused events in the back half of the

Read more...

USA Q2 Revenue 2024 Down 11% To $ 213 Million

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 29, 2024.
Key Financial & Operating Results

Second quarter net sales were $213 million versus $238 million during Q2 2023.
Second quarter diluted EPS was $0.54 as compared with $0.89 during Q2 2023.
Company updates fiscal year 2024 net sales and diluted EPS outlook to $850 million to $880 million and $2.40 to $2.55 (previously $850 million to $920 million and $2.40 to $3.00).

“Second quarter operating results were below our expectations,”

said Jim Brown, President and Chief Executive Officer.

“Ongoing macroeconomic pressures in several of our key markets continue to impact consumer spending. This in turn creates challenges in our ability to attract and engage new customers and generate sales momentum.
To counter these challenges, we have made several strategic changes in our business over the past few quarters, including (i) restructuring our commercial team, (ii) heightening our focus on product innovation, (iii) increasing our efforts to engage our sales leaders with an Associate-first approach, (iv) expanding into India, and (v) evaluating more business development activities.
“Next month, we will be hosting our Americas & Europe Convention in Las Vegas, Nevada along with other Associate engagement-focused events in the back half of the year. We are also planning to offer a more robust promotional calendar throughout the remainder of the year.”

Balance Sheet and Share Repurchase Activity
The Company generated $8 million in operating

Read more...

USANA Executives Make First Visit To New India Market

CEO Jim Brown visits the country to meet the local team, leaders, and share long-term vision for the market.
Reaching one million active customers is the first step towards USANA Health Sciences, Inc.’s mission of building the healthiest family on earth—making international expansion a critical initiative.
In late 2023, USANA opened its business to the India market, and for the first time since that opening, USANA’s President and CEO Jim Brown will be visiting the country. Mr. Brown will be accompanied by USANA’s Chief Sales Officer David Mulham and Vice President of Market Expansion & Ethics Dan Whitney.
The group will tour the company’s office in Gurgaon and meet with the local team that boasts more than 100 years of combined industry expertise. The visiting executives will then present USANA’s vision and long-term commitment to the India market in front of the strong, emerging, and progressive members of the USANA India family.
Jim Brow said:

“I am very much looking forward to my first visit to our India market and to meeting our amazing USANA India members. We spent many years preparing to open this strategically important market, and we believe USANA is well-aligned with India’s emphasis on family, wellness, and entrepreneurialism.
Growing USANA in one

Read more...

284 USANA-Sponsored Athletes In 2024 Summer Olympic Games In France

USANA Health Sciences, Inc. wishes the very best for the 284 sponsored USANA Athletes who earned their spot at the 2024 Summer Olympic and Paralympic Games in Paris. These athletes represent 10 nations including Canada, China, France, Indonesia, Italy, Mexico, Malaysia, South Korea, Spain, and the United States.

“USANA has been the go-to nutritional supplier for countless Olympic athletes for more than a decade. We are so excited to see our USANA Athletes go for Gold,”

said Brent Neidig, USANA’s chief commercial officer.

“No matter the outcome, we are proud of every athlete who has put their faith in USANA and our products to help their Olympic journey. All of us here at USANA are behind them all the way—we can’t wait to watch them compete.”

USANA partners with both individual athletes and national sporting organizations / teams.*
Summer Olympic Teams and Organizations Partnered with USANA:

Mexico Olympic Soccer Team, 22 athletes
USA Swimming, 46 athletes
USA Wrestling, 16 athletes
China National Sports Training Center, 182 athletes
Artistic Swimming, 9 athletes
Athletics, 56 athletes
Badminton, 16 athletes
Basketball, 16 athletes
Diving, 10 athletes
Gymnastics, 17 athletes
Swimming, 31 athletes
Table Tennis, 8 athletes
Volleyball, 13 athletes
Weightlifting, 6 athletes

Individual USANA Athletes:

Alex Portal—Para Swimming, France
Azzahra Permatahani—Swimming, Indonesia
Brooks Curry—Swimming, USA
Cheah Liek Hou—Para Badminton, Malaysia
Eduardo Lorrio—Water Polo, Spain
Jendi Pangabean—Para Swimming, Indonesia
Jeon

Read more...

USANA Q1 Revenue 2024 Down 8% To $228 Million

Key Financial & Operating Results

First quarter net sales were $228 million versus $248 million during Q1 2023, and increased 2% sequentially in constant currency.
First quarter diluted EPS was $0.86 as compared with $0.95 during Q1 2023.
Company reiterates fiscal year 2024 net sales and diluted EPS outlook of $850 million to $920 million and $2.40 to $3.00.

“Our top line results during the first quarter were driven by a successful sales incentive in mainland China, which helped counter the seasonal slowdown that we experience during the Lunar New Year holiday,”

said Jim Brown, President and Chief Executive Officer.

“This sales incentive helped us generate 15% year-over-year active customer growth in our largest market, as well as year-over-year and sequential quarter sales growth. Notwithstanding our solid performance in China, our first quarter results in other key markets did not meet internal expectations and we are actively working to accelerate our business in these markets during 2024.

Doug Hekking, Chief Financial Officer said:

“Strength in our mainland China operations carried our first quarter results. This performance helped offset softness in many other markets where we continue to face a challenging operating environment highlighted by ongoing inflationary pressures. We remain committed to engaging with Associate leaders throughout each

Read more...

USANA Reports Second Q2 Sales of $238 Million

USANA Health Sciences (NYSE: USNA) recently announced its financial results for the second fiscal quarter ending July 1, 2023.
The company achieved second quarter net sales of $238 million during this period, compared to $264 million in the second quarter of 2022. Diluted EPS was $0.89, down from $1 in the second quarter of 2022. The company’s active customers totaled 487,000, a 13% decline from the same quarter of 2022, and a 1% decline sequentially.
The Asia Pacific region led as the strongest market for the company, with $194 million in net sales and 384,000 active customers, representing an 11% and 12% decline respectively from the second quarter of 2022. Americas and Europe accounted for $44 million in net sales and 103,000 active customers.
“Our strategic focus remains squarely on increasing the number of Active Customers,”
said Jim Brown, USANA President and Chief Executive Officer.
“In addition to the emphasis on in-person meetings and events, our efforts include new market expansion, incentive opportunities for our salesforce, the ongoing pursuit of accretive acquisition opportunities, and expanding our digital commerce capabilities.
We remain optimistic that the successful execution of our strategies will position USANA for a return to long-term growth.”
USANA updated its fiscal 2023 net sales

Read more...

USANA Plans to Expand Into India

USANA Health Sciences, Inc. (NYSE: USNA) recently announced its plans to expand into India in the second half of 2023.
Expansion into India increases the Company’s global footprint to 25 markets.
“USANA’s expansion into India is our first new market in five years and provides an exciting and gratifying opportunity to introduce USANA’s world class health and wellness products to a new country, culture and demographic,”
said Jim Brown, President.
“We have spent several years of extensive research and meticulous work to prepare for this expansion into India.
We are confident that our products and business model are ideally suited for India, and we believe in our team’s ability to develop and grow this important market as we work toward our vision of creating the healthiest family on earth.
“While we are optimistic about the long-term growth opportunity that India presents, we also recognize that there will be learning opportunities as we serve an entirely new culture.
As such, we will take a deliberate and diligent approach to launching this market and executing our long-term growth strategy.”
The Company expects to officially launch operations in India near the end of the third quarter of 2023 and anticipates that this new market will contribute modestly to

Read more...

USANA Appoints Jim Brown As CEO

USANA Health Sciences, Inc. (NYSE: USNA) announced that consistent with the Company’s planned succession strategy, Kevin Guest, USANA’s Chief Executive Officer (CEO) since 2015 and Chairman of the Board since 2020, will transition to the role of Executive Chairman of the Company, effective July 1, 2023. At that time, Jim Brown, USANA’s current President, will be named CEO of the Company.
“It has been my great privilege to be part of USANA for over 30 years and to serve as CEO of this remarkable company for the last 8 years. I express my sincere appreciation for, and confidence in, USANA’s extraordinary management team, employees and Associates for their relentless work in advancing USANA’s position as one of the foremost leaders in health and wellness.
I look forward to my new role as Executive Chairman of the Company, where I will continue to be deeply involved in setting and advancing the Company’s strategy and mission.”
Gilbert Fuller, lead independent director of USANA’s Board of Directors said
“During his tenure with USANA, Kevin’s leadership, contributions, and passion for USANA’s mission and values have been immeasurable. As we move through this planned leadership transition, we look forward to Kevin’s ongoing involvement with the Company as Executive

Read more...

USANA Sales 2022 Down 16% To $999 Million

USANA Health Sciences, Inc. announced financial results for its fiscal fourth quarter and full year ended December 31, 2022.
Key Financial & Operating Results

Fourth quarter net sales were $228 million versus $267 million during the prior-year period.
Fourth quarter diluted EPS was $0.66 as compared with $1.03 during Q4 2021.
Fiscal year 2022 net sales were $999 million as compared with $1,186 million during fiscal year 2021.
Fiscal year 2022 diluted EPS totaled $3.59 versus $5.73 during fiscal year 2021.
Fiscal year 2022 operating cash flow totaled $104 million.
Company reiterates fiscal year 2023 net sales and diluted EPS outlook of $850 million to $950 million and $2.35 to $3.30, respectively.

“Our fourth quarter and full year results were largely in line with our preliminary results announced on January 5, 2023,”
said Kevin Guest, Chief Executive Officer and Chairman of the Board.
“During the fourth quarter, total Active Customer counts stabilized in several key markets and increased 3% sequentially. In addition, sales and customer activity in mainland China increased during the final two weeks of the year following the Chinese government’s unanticipated shift in COVID policy. This increase in sales and customer activity was due largely to increased demand for several of our health products in China.”
“While 2022

Read more...

USANA Acquires Network Marketing Company Oola

USANA Health Sciences, Inc. (NYSE: USNA) today announced the acquisition of two companies—Rise Bar and Oola.

“The acquisition of these emerging companies is part of USANA’s long-term growth strategy”

These emerging companies share USANA’s health and wellness focus while offering distinct channels or products. Rise Bar manufactures and sells high-quality protein bars that are formulated to help customers achieve their health goals through clean and simple ingredients.
Oola is an emerging direct selling company that offers a personal development framework that helps individuals create a life of balance, growth, and purpose.
Although Rise Bar and Oola will continue to operate and grow independently, USANA plans to leverage the knowledge, experience, and technology of these companies to advance USANA’s core business. Likewise, USANA will utilize its assets and resources to facilitate growth for Rise Bar and Oola.
“The acquisition of these emerging companies is part of USANA’s long-term growth strategy,”
said Kevin Guest, Chief Executive Officer and Chairman of the Board.
“We are committed to improving the health and wellness of individuals around the world. While USANA is a leader in many aspects, we recognize that we can accelerate this effort and reach more individuals through strategic acquisitions that align with our corporate values and mission.
“Both Rise

Read more...